Skip to main content

TUDOR INVESTMENT CORP ET AL

Position in CTMX — CytomX Therapeutics, Inc.

CIK 923093 STAMFORD, CT

Position in CTMX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,177,576
+$5,081,951 QoQ
Shares Held
1,380,687
+3047.6% QoQ
Ownership
0.634%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#29
of 178 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 50% Shared 50% None 0%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Derivatives in CTMX

reported options exposure · as of Jun 30, 2026
CallValue
$188,625
CallShares
50,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. CTMX ranks #16 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $188,625 50,300
2026-06-30 $5,177,576 1,380,687
2024-03-31 $95,625 43,865
2023-12-31 $69,331 44,730
2023-09-30 $57,701 44,730
2023-06-30 $76,935 44,730
2023-03-31 $67,542 44,730
2022-12-31 $260,795 162,997
2022-09-30 $236,345 162,997
2022-06-30 $298,284 162,997
2022-03-31 $435,201 162,997
2020-12-31 $339,768 51,873
2020-09-30 $657,957 98,941
2020-06-30 $204,676 24,571
2020-03-31 $332,041 43,291